The information highlighted (if any) are the most recent updates for this brand.
Epclusa is indicated for the treatment of chronic hepatitis C virus (HCV) infection in patients aged 12 years and older and weighing at least 30 kg (see Dosage & Administration, Precautions, and Pharmacology: Pharmacodynamics under Actions).